These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15613314)

  • 21. Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen.
    Peut V; Kent SJ
    J Virol; 2007 Dec; 81(23):13125-34. PubMed ID: 17898063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    Billings E; Sanders-Buell E; Bose M; Bradfield A; Lei E; Kijak GH; Arroyo MA; Kibaya RM; Scott PT; Wasunna MK; Sawe FK; Shaffer DN; Birx DL; McCutchan FE; Michael NL; Robb ML; Kim JH; Tovanabutra S
    PLoS One; 2015; 10(8):e0135124. PubMed ID: 26287814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technology.
    Park H; Chung YS; Yoon CH; Lee SH; Kim SS; Kang C; Choi BS
    HIV Med; 2016 Jun; 17(6):460-6. PubMed ID: 26471354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.
    Li F; Malhotra U; Gilbert PB; Hawkins NR; Duerr AC; McElrath JM; Corey L; Self SG
    Vaccine; 2006 Nov; 24(47-48):6893-904. PubMed ID: 16890329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.
    Madhavi V; Wren LH; Center RJ; Gonelli C; Winnall WR; Parsons MS; Kramski M; Kent SJ; Stratov I
    AIDS; 2014 Aug; 28(13):1859-70. PubMed ID: 24937308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
    Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.
    Kundu SK; Dupuis M; Sette A; Celis E; Dorner F; Eibl M; Merigan TC
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1669-78. PubMed ID: 9870321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
    Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
    Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor.
    Zhu T; Wang N; Carr A; Wolinsky S; Ho DD
    J Virol; 1995 Feb; 69(2):1324-7. PubMed ID: 7815515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
    Moss RB; Giermakowska W; Lanza P; Turner JL; Wallace MR; Jensen FC; Theofan G; Richieri SP; Carlo DJ
    Viral Immunol; 1997; 10(4):221-8. PubMed ID: 9473153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superinfection with a heterologous HIV strain per se does not lead to faster progression.
    Fung IC; Gambhir M; van Sighem A; de Wolf F; Garnett GP
    Math Biosci; 2010 Mar; 224(1):1-9. PubMed ID: 19932122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune response to human immunodeficiency virus.
    Norris PJ; Rosenberg ES
    AIDS; 2001 Feb; 15 Suppl 2():S16-21. PubMed ID: 11424972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.
    Ramos A; Hu DJ; Nguyen L; Phan KO; Vanichseni S; Promadej N; Choopanya K; Callahan M; Young NL; McNicholl J; Mastro TD; Folks TM; Subbarao S
    J Virol; 2002 Aug; 76(15):7444-52. PubMed ID: 12097556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic HIV-1 infection frequently fails to protect against superinfection.
    Piantadosi A; Chohan B; Chohan V; McClelland RS; Overbaugh J
    PLoS Pathog; 2007 Nov; 3(11):e177. PubMed ID: 18020705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV drug resistance acquired through superinfection.
    Smith DM; Wong JK; Hightower GK; Ignacio CC; Koelsch KK; Petropoulos CJ; Richman DD; Little SJ
    AIDS; 2005 Aug; 19(12):1251-6. PubMed ID: 16052079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus.
    Koelsch KK; Smith DM; Little SJ; Ignacio CC; Macaranas TR; Brown AJ; Petropoulos CJ; Richman DD; Wong JK
    AIDS; 2003 May; 17(7):F11-6. PubMed ID: 12700477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.